Guangzhou Jointas Chemical Co.Ltd(002909) independent director
Independent opinions on matters related to the sixth meeting of the third board of directors
As an independent director of Guangzhou Jointas Chemical Co.Ltd(002909) (hereinafter referred to as “the company”), he carefully reviewed and verified the relevant matters considered at the sixth meeting of the third board of directors of the company in accordance with the relevant provisions of the rules for independent directors of listed companies, the stock listing rules of Shenzhen Stock exchange, the working system of Guangzhou Jointas Chemical Co.Ltd(002909) independent directors and other relevant rules and regulations. Based on his independent judgment, We hereby express the following independent opinions on the relevant situation:
1、 Independent opinions on the proposal on the prediction of daily connected transactions in 2022
The daily related party transactions expected by the company in 2022 are normal commercial transactions, which are conducted on the basis of fairness, impartiality and mutual benefit based on the needs of daily operation. The prices of related party transactions are determined with reference to the market price, which will not damage the interests of the company and minority shareholders, nor affect the independence, financial status and Adverse impact on operating results. When the board of directors of the company deliberated the proposal on the prediction of daily connected transactions in 2022, Zou Zhenfu, a connected director, avoided voting, and the voting procedures met the relevant provisions of the Listing Rules of Shenzhen Stock Exchange and the articles of association, so he agreed to the proposal.
2、 Independent opinions on the proposal on continuing to use some idle raised funds for cash management
The company uses the temporarily idle raised funds for cash management without affecting the normal progress of the investment plan of the raised funds, the safety of the funds and the normal production and operation of the company, which is conducive to improving the use efficiency of the funds, further increasing the company’s income and protecting the interests of the company’s shareholders. The company’s use of part of the raised funds for cash management this time complies with relevant laws and regulations such as the guidelines for the supervision of listed companies No. 2 – regulatory requirements for the management and use of raised funds by listed companies, the stock listing rules of Shenzhen Stock Exchange and the guidelines for the self discipline supervision of listed companies of Shenzhen Stock Exchange No. 1 – standardized operation of listed companies on the main board, It is in line with the interests of the company and all shareholders, and there is no case of changing the purpose of the raised funds in a disguised form, or damaging the interests of the company and all shareholders, especially small and medium-sized shareholders. We agree that the company shall use the temporarily idle raised funds of no more than RMB 166 million for cash management, and the service life shall not exceed 12 months from the date of deliberation and approval by the board of directors.
3、 Independent opinions on the proposal on continuing to use some idle raised funds to supplement working capital temporarily
The company uses some idle raised funds to temporarily supplement working capital, which is conducive to reducing the company’s financial expenses, improving the use efficiency of raised funds, and meeting the needs of safeguarding the development interests of the company and maximizing the interests of shareholders; The use of the raised funds will not affect the normal progress of the investment projects of the raised funds, and there is no disguised change in the purpose of the raised funds and damage to the interests of shareholders. We agree that the company will use the idle raised funds of no more than 100 million yuan to temporarily supplement the working capital, and the service life shall not exceed 12 months from the date of deliberation and approval by the board of directors.
(there is no text on this page, which is the signature page of Guangzhou Jointas Chemical Co.Ltd(002909) independent directors’ independent opinions on relevant matters of the sixth meeting of the third board of directors of the company)
independent director:
Xu Songlin, Wu zhanchi, Tang Qian
specific date
